Report of a WHO workshop on the standardization and control of antivenoms

This publication has 11 references indexed in Scilit:

• Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol
  Toxicon, 2001
• An in vivo but insensate model for the evaluation of antivenoms (ED 50 ) using fertile hens' eggs
  Toxicon, 2000
• Scorpion envenomation and serotherapy in Morocco.
  The American Journal of Tropical Medicine and Hygiene, 2000
• Serotherapy in scorpion envenomation: a randomised controlled trial
  The Lancet, 1999
• Pharmacokinetics of 125I-labelled IgG, F(ab′)2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use
  Toxicon, 1998
• Pharmacokinetics of 125I-labelled Walterinnesia aegyptia venom and its specific antivenins: flash absorption and distribution of the venom and its toxin versus slow absorption and distribution of IgG, F(ab′)2 and F(ab) of the antivenin
  Toxicon, 1998
• Immunoglobulin G and F(ab′)2 polyvalent antivenoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom
  Toxicon, 1997
• The use of synthetic peptides can be a misleading approach to generate vaccines against scorpion toxins
  Vaccine, 1995
• Snake antivenoms from hyperimmunized horses: Comparison of the antivenom activity and biological properties of their whole IgG and F(ab′)2 fragments
  Toxicon, 1994
• Purification of F(ab′)2 anti-snake venom by caprylic acid: A fast method for obtaining IgG fragments with high neutralization activity, purity and yield
  Toxicon, 1989